Studies related to Diarrhea and Zinc

Zinc Gluconate Lozenges For Common Cold. A Double-blind Clinical Trial

Effect Decrease
Values Rate and percentage. Placebo: 16 (32.0 Zinc: 10 (20.0) Duration (median and IQR days). Placebo: 0.0 (0.0–1.0) Zinc: 0
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 100
Sex Both Genders
Age Range 7-12, 13-17
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 100 healthy children 8-13 years old were given 15 mg of zinc bis-glycinate chelate once daily or placebo for 3 months.

The primary outcome was the occurrence of any symptom of cold at any time during the 3-months. There was notably less cough and rhinorrhoea but more fever in the zinc group, but none of the differences were statistically significant. There was less vomiting, diarrhea, antibiotic use, school absence, or cold-related school absence, though none of these differences were statistically significant either. The number of participants with at least one symptom of coughs, fever, and rhinorrhoea wasn't different between groups, but the number experiencing 2 or 3 was nonsignificantly lower.

Coughs and rhinorrhoea lasted for significantly less time in the zinc groups.